316 related articles for article (PubMed ID: 8878276)
1. Maternal serum screening and trisomy 16 confined to the placenta.
Groli C; Cerri V; Tarantini M; Bellotti D; Jacobello C; Gianello R; Zanini R; Lancetti S; Zaglio S
Prenat Diagn; 1996 Aug; 16(8):685-9. PubMed ID: 8878276
[TBL] [Abstract][Full Text] [Related]
2. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
3. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
[TBL] [Abstract][Full Text] [Related]
4. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Hogge WA; Fraer L; Melegari T
Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
[TBL] [Abstract][Full Text] [Related]
6. Confined placental mosaicism for trisomy 14 and maternal uniparental disomy in association with elevated second trimester maternal serum human chorionic gonadotrophin and third trimester fetal growth restriction.
Towner DR; Shaffer LG; Yang SP; Walgenbach DD
Prenat Diagn; 2001 May; 21(5):395-8. PubMed ID: 11360282
[TBL] [Abstract][Full Text] [Related]
7. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
[TBL] [Abstract][Full Text] [Related]
8. Maternal uniparental disomy for chromosome 2 in association with confined placental mosaicism for trisomy 2 and severe intrauterine growth retardation.
Webb AL; Sturgiss S; Warwicker P; Robson SC; Goodship JA; Wolstenholme J
Prenat Diagn; 1996 Oct; 16(10):958-62. PubMed ID: 8938070
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum screening.
Carroll JC
Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
[TBL] [Abstract][Full Text] [Related]
10. Prenatal biochemical diagnostics of inborn developmental defects.
Malbohan I; Fialová L; Mikulíková L; Hájek Z
Sb Lek; 1994; 95(4):277-83. PubMed ID: 8867698
[TBL] [Abstract][Full Text] [Related]
11. [Maternal serum screening for Down syndrome and neural tube defects].
van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
[TBL] [Abstract][Full Text] [Related]
12. Invasive testing for the karyotyping of mid-trimester intrauterine fetal death (IUFD): a pilot study.
Howarth ES; Konje JC; Healey KA; Duckett DP; Scudamore IW; Taylor DJ
Prenat Diagn; 2002 Jun; 22(6):453-5. PubMed ID: 12116301
[TBL] [Abstract][Full Text] [Related]
13. Postnatal placental confirmation of trisomy 2 and trisomy 16 detected at chorionic villus sampling: a possible association with intrauterine growth retardation and elevated maternal serum alpha-fetoprotein.
Fryburg JS; Dimaio MS; Mahoney MJ
Prenat Diagn; 1992 Mar; 12(3):157-62. PubMed ID: 1375377
[TBL] [Abstract][Full Text] [Related]
14. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
16. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of an infant with mosaic trisomy 16 of paternal origin.
Paulyson KJ; Sherer DM; Christian SL; Lewis KM; Ledbetter DH; Salafia CM; Meck JM
Prenat Diagn; 1996 Nov; 16(11):1021-6. PubMed ID: 8953635
[TBL] [Abstract][Full Text] [Related]
18. Analysis of nine pregnancies with confined placental mosaicism for trisomy 2.
Shaffer LG; Langlois S; McCaskill C; Main DM; Robinson WP; Barrett IJ; Kalousek DK
Prenat Diagn; 1996 Oct; 16(10):899-905. PubMed ID: 8938058
[TBL] [Abstract][Full Text] [Related]
19. Contemporary approaches to prenatal diagnosis.
Kuller JA; Laifer SA
Am Fam Physician; 1995 Dec; 52(8):2277-83, 2285-6. PubMed ID: 7484721
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
